Cytodyn Inc (CYDY)

[finesand]

just updated myself about my limited biotech 'going alone' watchlist: $SGYPQ (BK) now being followed by $AKAO (wow, also filed for CH11 recently).
$DVAX still has 1.4 quarters of equity to burn until debt outweighs their cash - SP shows it is also getting close.

Just to document my reasoning against this 'going alone' "idea" for $CYDY. When they can't even properly plan trials even with a renewed upgraded management (RP at helm for TNBC), how can they master the even more complex task of commercialization?

IMHO, management needs a very cold shower instead of posting videos on the pay per show venue, which just ends up on youtube anyways. Maybe NP should simply start blogging, that would suffice.

Bottom line: Waiting out the financing rounds to come.
May is here soon anyways.